Anti-Human Anthrax Toxin Receptor (CT) (ATR)

Home/Primary Monoclonal Antibodies/Infectious Diseases/Anti-Human Anthrax Toxin Receptor (CT) (ATR)

Pricing & Details

Product No.A287
Protein
Anthrax Toxin Receptor
Formats AvailableView All
Product Type
Polyclonal Antibody
Alternate Names
TEM8
Applications
IHC FFPE
,
WB
Prod No.
Size
Price
Avail.
Qty
Add to cart
A287-20ug
20 µg
$195.00
In stock
Max:
Min: 1
Step: 1
A287-0.1 mg
0.1 mg
$397.00
In stock
Max:
Min: 1
Step: 1
Bulk quantities available. Contact us for pricing.

Antibody Details

Product Details

Reactivity Species
Human
Host Species
Rabbit
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Human Anthrax Toxin Receptor (ATR) recognizes an epitope near the C-terminus of Human, Mouse and Rat ATR. This polyclonal antibody was purified using affinity chromatography.
Background
The Anthrax toxin receptor (ATR) was initially discovered as the tumor endothelial marker 8 (TEM8).1 This protein, which exists in three isoforms (36, 40, and 60 kDa), is highly expressed in tumor vessels as well as in the vasculature of developing embryos, suggesting that it may normally play a role in angiogenesis. However, it also acts as the receptor for anthrax toxin.2 Following the binding of this protein by the protective antigen (PA) of anthrax, PA is cleaved and heptamerizes to form the binding site for both edema factor (EF) and lethal factor (LF).3 This complex is then endocytosed by the cell; acidification in endosomes allows the release of EF and LF into the cytoplasm where they interfere with MAPK signaling and induce apoptosis.4

Antigen Details

References & Citations

1. Carson-Walter, E. B. et al. (2001) Can. Res. 61:6649 2. Bradley, K. A. et al. (2001) Nature 414:225 3. Molloy, S. et al. (1992) J. Biol. Chem. 267:16396 4. Duesbery, N. et al. (1998) Science 280:734
IHC
General Western Blot Protocol
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok